ArticleLife science alliance2022

TICAM-1/TRIF associates with Act1 and suppresses IL-17 receptor-mediated inflammatory responses.

Yusuke Miyashita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.